UnitedHealth Group (NYSE:UNH) had its price objective hoisted by Royal Bank Of Canada to $244.00 in a research note published on Wednesday, The Fly reports. The brokerage currently has an outperform rating on the healthcare conglomerate’s stock. The analysts noted that the move was a valuation call.

Several other analysts also recently issued reports on UNH. Cowen reaffirmed an outperform rating and set a $220.00 price objective (up from $175.00) on shares of UnitedHealth Group in a report on Friday, August 11th. Wells Fargo & Company reaffirmed an outperform rating and set a $245.00 price objective (up from $230.00) on shares of UnitedHealth Group in a report on Wednesday. Oppenheimer increased their price target on shares of UnitedHealth Group from $215.00 to $225.00 and gave the company an outperform rating in a report on Wednesday. Cantor Fitzgerald reissued a buy rating and issued a $225.00 price target on shares of UnitedHealth Group in a report on Monday, November 27th. Finally, Zacks Investment Research downgraded shares of UnitedHealth Group from a buy rating to a hold rating in a report on Tuesday, September 26th. Three equities research analysts have rated the stock with a hold rating and twenty-three have given a buy rating to the stock. UnitedHealth Group has an average rating of Buy and a consensus price target of $224.56.

Shares of UnitedHealth Group (NYSE:UNH) opened at $226.78 on Wednesday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70. The stock has a market cap of $221,112.13, a price-to-earnings ratio of 23.77, a P/E/G ratio of 1.69 and a beta of 0.65. UnitedHealth Group has a 1-year low of $156.09 and a 1-year high of $229.22.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.57 by $0.09. The business had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. UnitedHealth Group’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.17 EPS. analysts anticipate that UnitedHealth Group will post 9.99 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st will be paid a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.32%. The ex-dividend date of this dividend is Thursday, November 30th. UnitedHealth Group’s dividend payout ratio is 33.26%.

In other news, insider Thomas E. Roos sold 975 shares of the stock in a transaction on Thursday, October 19th. The shares were sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the transaction, the insider now owns 24,630 shares in the company, valued at approximately $5,060,726.10. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Gail R. Wilensky sold 5,600 shares of the stock in a transaction on Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the completion of the transaction, the director now owns 60,834 shares of the company’s stock, valued at approximately $12,135,774.66. The disclosure for this sale can be found here. In the last 90 days, insiders sold 63,206 shares of company stock valued at $12,683,669. Corporate insiders own 0.89% of the company’s stock.

Several hedge funds have recently made changes to their positions in the company. Regal Wealth Group Inc. increased its position in shares of UnitedHealth Group by 0.4% during the 2nd quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock worth $138,000 after purchasing an additional 3 shares in the last quarter. Jackson Grant Investment Advisers Inc. increased its position in shares of UnitedHealth Group by 0.4% during the 2nd quarter. Jackson Grant Investment Advisers Inc. now owns 1,101 shares of the healthcare conglomerate’s stock worth $204,000 after purchasing an additional 4 shares in the last quarter. RB Capital Management LLC increased its position in shares of UnitedHealth Group by 0.4% during the 2nd quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock worth $321,000 after purchasing an additional 7 shares in the last quarter. Altfest L J & Co. Inc. increased its position in shares of UnitedHealth Group by 0.3% during the 2nd quarter. Altfest L J & Co. Inc. now owns 2,963 shares of the healthcare conglomerate’s stock worth $549,000 after purchasing an additional 10 shares in the last quarter. Finally, Highland Private Wealth Management increased its position in shares of UnitedHealth Group by 0.4% during the 2nd quarter. Highland Private Wealth Management now owns 3,199 shares of the healthcare conglomerate’s stock worth $593,000 after purchasing an additional 13 shares in the last quarter. Institutional investors own 86.20% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was first posted by Daily Political and is owned by of Daily Political. If you are accessing this news story on another website, it was stolen and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this news story can be read at https://www.dailypolitical.com/2017/12/02/unitedhealth-group-unh-price-target-raised-to-244-00.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

The Fly

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.